The Latest Breaking News from NYSE

Brown Forman: Q3 Earnings Insights

  Brown Forman Inc Class B Common Stock (NYSE:BF) reported its Q3 earnings results on Thursday, March 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 3, 2022

Kroger Shares Gain On Q4 Earnings Beat, Robust FY22 Outlook

Kroger Co (NYSE:KR) reported fourth-quarter FY21 sales growth of 7.5% year-on-year, to $33.05 billion, beating the consensus of $32.86 billion. Identical Sales without fuel increased 4%; the two-year stack increased 14.6%. Digital sales two-year stack grew 105%. Adjusted EPS of $0.91 beat the consensus of $0.74. The gross margin was 22.2%, and the…

Benzinga · Mar 3, 2022

Gap Shares Could Move This Much After Q4 Earnings

Gap Inc (NYSE: GPS) reports earnings Thursday after the bell. Shares of Gap rose 5.43% to close Wednesday’s trading at $14.57.

Benzinga · Mar 3, 2022

Here's How Much $1000 Invested In Snowflake 5 Years Ago Would Be Worth Today

Snowflake (NYSE:SNOW) has outperformed the market over the past 5 years by 45.2% on an annualized basis.

Benzinga · Mar 3, 2022

Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters

Pfizer Inc (NYSE:PFE) is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries in 2022, reports Reuters citing an official with the Global Fund. The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed at least that many…

Benzinga · Mar 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022

Upgrades

Benzinga · Mar 3, 2022

What 4 Analyst Ratings Have To Say About Jackson Financial

Analysts have provided the following ratings for Jackson Financial (NYSE:JXN) within the last quarter:

Benzinga · Mar 3, 2022

WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients

A World Health Organization (WHO) panel has backed the use of Merck & Co Inc's (NYSE:MRK) COVID-19 antiviral pill for high-risk patients. The expert panel conditionally recommended molnupiravir for patients with non-severe disease at high risk of hospitalization, such as the immunocompromised, the unvaccinated, older people, and those with chronic conditions. The recommendation was…

Benzinga · Mar 3, 2022

This Foreboding Sign Looms Over Quest Diagnostics's Chart

If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga · Mar 3, 2022

Southwest Gas Holdings Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Southwest Gas Holdings (NYSE:SWX) earned $71.18 million, a 865.84% increase from the preceding quarter. Southwest Gas Holdings's sales decreased to $451.21 million, a 49.23% change since Q3.

Benzinga · Mar 3, 2022